Insights

Strategic Industry Partnerships Abolis Biotechnologies has established high-profile collaborations with major companies such as L'Oréal, Evonik, and EuroAPI, indicating a strong interest in developing innovative and sustainable ingredients. These partnerships open opportunities for offering advanced biotech solutions, custom formulations, or complementary technologies to enhance their collaborative projects.

Funding and Growth Initiatives Recent significant investments and strategic €140 million alliance demonstrate Abolis's active expansion and innovation ambitions. Business development efforts can focus on proposing solutions that align with their growth plans, such as scalable manufacturing technologies or R&D tools that support rapid innovation in biotech applications.

Focus on Sustainability Abolis emphasizes reducing greenhouse gases and utilizing renewable raw materials, highlighting their commitment to eco-friendly processes. Sales opportunities exist in offering sustainable raw material sourcing, green laboratory equipment, or eco-conscious supply chain solutions that complement their environmental objectives.

Customization and Innovation The company's tailored approach to solving industry challenges through multidisciplinary expertise suggests a need for innovative, flexible biotech solutions and technology platforms that enable bespoke product development and accelerate time-to-market for their clients.

Emerging Market Presence Operating in a competitive biotech landscape with a focus on high-impact innovations, Abolis is positioned for expansion into markets like healthcare, cosmetics, and chemicals. Sales strategies could target providing cutting-edge synthetic biology tools, high-yield bioprocessing systems, or regulatory-compliant biochemicals to support their market diversification.

Abolis Biotechnologies Tech Stack

Abolis Biotechnologies uses 8 technology products and services including jsDelivr, cdnjs, Swiper, and more. Explore Abolis Biotechnologies's tech stack below.

  • jsDelivr
    Content Delivery Network
  • cdnjs
    Content Delivery Network
  • Swiper
    Javascript Libraries
  • Lodash
    Javascript Libraries
  • PHP
    Programming Languages
  • X-Content-Type-Options
    Web & Portal Technology
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers

Abolis Biotechnologies's Email Address Formats

Abolis Biotechnologies uses at least 1 format(s):
Abolis Biotechnologies Email FormatsExamplePercentage
First.Last@abolis.frJohn.Doe@abolis.fr
50%
First.Last@abolis.frJohn.Doe@abolis.fr
50%

Frequently Asked Questions

Where is Abolis Biotechnologies's headquarters located?

Minus sign iconPlus sign icon
Abolis Biotechnologies's main headquarters is located at 5 Rue Henri Desbruères Évry, Île-de-france 91030 France. The company has employees across 4 continents, including EuropeAsiaNorth America.

What is Abolis Biotechnologies's official website and social media links?

Minus sign iconPlus sign icon
Abolis Biotechnologies's official website is abolis.fr and has social profiles on LinkedInCrunchbase.

What is Abolis Biotechnologies's SIC code NAICS code?

Minus sign iconPlus sign icon
Abolis Biotechnologies's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Abolis Biotechnologies have currently?

Minus sign iconPlus sign icon
As of March 2026, Abolis Biotechnologies has approximately 65 employees across 4 continents, including EuropeAsiaNorth America. Key team members include Chief Scientific Officer: G. B.Vp Operations | Head Of Operations, Transformation & Change Management: F. A.Head Of Business Development, North America: F. S.. Explore Abolis Biotechnologies's employee directory with LeadIQ.

What industry does Abolis Biotechnologies belong to?

Minus sign iconPlus sign icon
Abolis Biotechnologies operates in the Biotechnology Research industry.

What technology does Abolis Biotechnologies use?

Minus sign iconPlus sign icon
Abolis Biotechnologies's tech stack includes jsDelivrcdnjsSwiperLodashPHPX-Content-Type-OptionsGoogle AnalyticsApache HTTP Server.

What is Abolis Biotechnologies's email format?

Minus sign iconPlus sign icon
Abolis Biotechnologies's email format typically follows the pattern of First.Last@abolis.fr. Find more Abolis Biotechnologies email formats with LeadIQ.

When was Abolis Biotechnologies founded?

Minus sign iconPlus sign icon
Abolis Biotechnologies was founded in 2014.

Abolis Biotechnologies

Biotechnology ResearchÎle-de-france, France51-200 Employees

Abolis is a French company delivering high-impact innovations in biotechnologies. We provide tailor-made industrial solutions based on micro-organisms.
Founded in 2014, Abolis is made up of a team of 66+ people. Determined to become a key player in the transformation of manufacturing, we reinvent the future of numerous industries - from food to healthcare, cosmetics and chemicals.
We rely on biotechnologies and the untapped potential of micro-organisms to develop new solutions economically viable.  
We take up the industry's current challenges by: 
·      Using renewable raw materials 
·      Relocate essential production and secure supply chains
·      Reducing greenhouse gas emissions 

Because each customer has its own unique story and challenges, we cultivate a multidisciplinary, tailor-made approach. Science, economics, intellectual property, industrial realities: each of our answers is based on the best possible practices. 
We are…
independent in thought and action
rigorous in our approach and the way we work
creative because we never stop innovating, while remaining pragmatic
ambitious because we are passionate and determined to make a difference

Section iconCompany Overview

Headquarters
5 Rue Henri Desbruères Évry, Île-de-france 91030 France
Website
abolis.fr
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
51-200

Section iconFunding & Financials

  • $1M

    Abolis Biotechnologies's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Abolis Biotechnologies's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.